Januvia for Type 2 Diabetes
US$ 23.20
fda warning glp-1 november 2025 Scam warning: shoppers warned as thousands of social media pages target weight loss drug buyers FDA issued 25 warning letters
Description
Grocery spending in Britain has fallen by 780m over the past two years due to the growing use of GLP-1 weight loss drugs, according to new research from Worldpanel by Numerator.
95% CI 0.94, 1.03)
You understand that clinical trial outcomes do not constitute guarantees of effect
A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, especially with liraglutide and among people without diabetes or obesity.
Just clear and affordable access to a critical drug class
